Literature DB >> 11086018

Catalytic DNAs as potential therapeutic agents and sequence-specific molecular tools to dissect biological function.

L M Khachigian1.   

Abstract

Mesh：

Substances：

Year:  2000        PMID： 11086018      PMCID： PMC381443          DOI： 10.1172/JCI11620

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  49 in total

1.  DzyNA-PCR: use of DNAzymes to detect and quantify nucleic acid sequences in a real-time fluorescent format.

Authors:  A V Todd; C J Fuery; H L Impey; T L Applegate; M A Haughton
Journal:  Clin Chem       Date:  2000-05       Impact factor: 8.327

2.  Improved clinical outcome after widespread use of coronary-artery stenting in Canada.

Authors:  J M Brophy
Journal:  N Engl J Med       Date:  2000-05-11       Impact factor: 91.245

3.  Developing aptamers into therapeutics.

Authors:  R R White; B A Sullenger; C P Rusconi
Journal:  J Clin Invest       Date:  2000-10       Impact factor: 14.808

4.  Escort aptamers: a delivery service for diagnosis and therapy.

Authors:  B J Hicke; A W Stephens
Journal:  J Clin Invest       Date:  2000-10       Impact factor: 14.808

Review 5.  Nuclease-resistant synthetic ribozymes: developing a new class of therapeutics.

Authors:  N Usman; L M Blatt
Journal:  J Clin Invest       Date:  2000-11       Impact factor: 14.808

6.  Nucleic acid mutation analysis using catalytic DNA.

Authors:  M J Cairns; A King; L Q Sun
Journal:  Nucleic Acids Res       Date:  2000-02-01       Impact factor: 16.971

7.  New DNA enzyme targeting Egr-1 mRNA inhibits vascular smooth muscle proliferation and regrowth after injury.

Authors:  F S Santiago; H C Lowe; M M Kavurma; C N Chesterman; A Baker; D G Atkins; L M Khachigian
Journal:  Nat Med       Date:  1999-11       Impact factor: 53.440

8.  High-level expression of Egr-1 and Egr-1-inducible genes in mouse and human atherosclerosis.

Authors:  T A McCaffrey; C Fu; B Du; S Eksinar; K C Kent; H Bush; K Kreiger; T Rosengart; M I Cybulsky; E S Silverman; T Collins
Journal:  J Clin Invest       Date:  2000-03       Impact factor: 14.808

9.  Design of nuclease resistant protein kinase calpha DNA enzymes with potential therapeutic application.

Authors:  M Sioud; M Leirdal
Journal:  J Mol Biol       Date:  2000-02-25       Impact factor: 5.469

10.  Vascular smooth muscle cells express the transcriptional corepressor NAB2 in response to injury.

Authors:  E S Silverman; L M Khachigian; F S Santiago; A J Williams; V Lindner; T Collins
Journal:  Am J Pathol       Date:  1999-10       Impact factor: 4.307
View more
  20 in total

1.  Developing aptamers into therapeutics.

Authors:  R R White; B A Sullenger; C P Rusconi
Journal:  J Clin Invest       Date:  2000-10       Impact factor: 14.808

Review 2.  Electroporation of the vasculature and the lung.

Authors:  David A Dean
Journal:  DNA Cell Biol       Date:  2003-12       Impact factor: 3.311

3.  A novel replicating circular DNAzyme.

Authors:  Fei Chen; Ruijian Wang; Zhe Li; Bin Liu; Xiaoping Wang; Yanhong Sun; Dongyun Hao; Jin Zhang
Journal:  Nucleic Acids Res       Date:  2004-04-28       Impact factor: 16.971

4.  DNA computing circuits using libraries of DNAzyme subunits.

Authors:  Johann Elbaz; Oleg Lioubashevski; Fuan Wang; Françoise Remacle; Raphael D Levine; Itamar Willner
Journal:  Nat Nanotechnol       Date:  2010-05-30       Impact factor: 39.213

Review 5.  Nonviral gene transfer to skeletal, smooth, and cardiac muscle in living animals.

Authors:  David A Dean
Journal:  Am J Physiol Cell Physiol       Date:  2005-08       Impact factor: 4.249

6.  Effective inhibition of expression of hepatitis B virus genes by DNAzymes.

Authors:  Jian-Er Wo; Xiao-Ling Wu; Lin-Fu Zhou; Hang-Ping Yao; Li-Wei Chen; Reinhard-H Dennin
Journal:  World J Gastroenterol       Date:  2005-06-21       Impact factor: 5.742

Review 7.  Brothers in arms: DNA enzymes, short interfering RNA, and the emerging wave of small-molecule nucleic acid-based gene-silencing strategies.

Authors:  Ravinay Bhindi; Roger G Fahmy; Harry C Lowe; Colin N Chesterman; Crispin R Dass; Murray J Cairns; Edward G Saravolac; Lun-Quan Sun; Levon M Khachigian
Journal:  Am J Pathol       Date:  2007-08-23       Impact factor: 4.307

Review 8.  DNAzymes and cardiovascular disease.

Authors:  V L Benson; L M Khachigian; H C Lowe
Journal:  Br J Pharmacol       Date:  2008-05-05       Impact factor: 8.739

Review 9.  Recent developments in drug-eluting stents.

Authors:  Yue Li; Ravinay Bhindi; Levon M Khachigian
Journal:  J Mol Med (Berl)       Date:  2011-01-29       Impact factor: 4.599

10.  Melanoma protective antitumor immunity activated by catalytic DNA.

Authors:  Hong Cai; Eun-Ae Cho; Yue Li; Jim Sockler; Christopher R Parish; Beng H Chong; Jarem Edwards; Tristan J Dodds; Peter M Ferguson; James S Wilmott; Richard A Scolyer; Gary M Halliday; Levon M Khachigian
Journal:  Oncogene       Date:  2018-05-29       Impact factor: 9.867
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.